If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIngenta Regulatory News (ING)

Share Price Information for Ingenta (ING)

Share Price is delayed by 15 minutes
Get Live Data
65.00    0.00 (0.00%)
Bid:
64.00
Ask:
66.00
Spread: 2.00 (3.125%)
Market Cap: £9.43m
ING Live PriceLast checked at - London Stock Exchange

Intraday Ingenta Share Chart

Trading Update

7 Feb 2025 07:00

RNS Number : 2552W
Ingenta PLC
07 February 2025
 

7 February 2025

Ingenta plc

("Ingenta" or the "Company")

Trading Update

Ingenta plc (AIM: ING), a leading provider of software and services to the publishing and media industries, provides the following trading update for the year ended 31 December 2024 ("FY24").

In line with previous guidance, the Group expects to report revenues for FY24 of £10.2m (2023: £10.8m) and EBITDA of £1.8m (2023: £2.2m). The Group generated substantially improved positive cash flow during FY24 of £0.9m (2023: £0.3m), providing closing cash balances at 31 December 2024 of £3.6m. The Group has no debt.

The Board expects to recommend the payment of an unchanged final dividend for the year of 2.6 pence per share, taking the dividend for the year to a total of 4.1 pence.

During 2024, the Group's focus remained on implementing new projects based on new generation software platforms to offset the anticipated reduction in revenues from certain legacy services. As announced in September 2024, the Company experienced delays in implementing a number of these new projects and therefore did not fully offset the effects of legacy revenue reductions within FY24.

The Company is prioritising acceleration of new business acquisition to offset the expected larger scale reduction in revenues from legacy platforms in the current year and beyond and return the Company to growth in revenues and profits.

The momentum of new business wins is already accelerating: the Board is pleased to report four substantial new contracts won since the year end, with aggregate contract values of £1.9m over 2-5 years, broadly spread across the Edify, IngentaConnect and Commercial platforms. This equates to the total amount of new business won in the first half of 2024 and underpins management's confidence that the Group will resume growth in top line revenues in 2025.

In order to continue the Group's overall growth momentum beyond 2025, the Board has sanctioned a £0.5m investment in the Group's sales and marketing activities during 2025 in order to build a larger and longer term pipeline of new business. As a result of this investment, the Board expects that EBITDA for 2025 is likely to be lower than in 2024, despite the expectation of increased revenues referred to above.

Subject to trading remaining in line with expectations, the Board intends to retain the level of dividends for 2025 at the current level of 4.1p per share for the year.

 

Scott Winner, CEO of Ingenta, commented:

"I am pleased to report that we have won substantial new business in 2024, broadly based across all the Group's current platform offerings, and it is disappointing that delays in implementing these new services due to customer-induced delays have resulted in this impacting on the overall results for the year. The rate of new business wins has accelerated since the year end with four new clients, and an aggregate of £1.9m contract values, already in 2025, which provides us with a firm foundation on which to invest further in our sales and marketing resources.

Looking ahead to the longer term, this new investment will further reduce our reliance on revenues and profits from legacy platforms and aim to ensure that the transition of long-standing customers away from higher-value legacy products will be more than offset by increasing new business from our current and next generation offerings. Although this will impact on profits in 2025, it is an investment in the future which we expect to bear fruit in accelerating growth in future years."

Certain information contained in this announcement would have been deemed inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time, until the release of this announcement.

For further information please contact:

Ingenta plc Tel: 01865 397 800

Scott Winner/Jon Sheffield

Cavendish Capital Markets Limited Tel: 0207 220 0500

Katy Birkin / Callum Davidson

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVQLFBELLBBBD
Date   Source Headline
10th Dec 20197:00 amRNSGrant of Options
18th Nov 20191:53 pmRNSDirector/PDMR Shareholding
14th Nov 20195:06 pmRNSTransaction in Own Shares
28th Oct 20197:00 amRNSContract Wins
17th Oct 20197:00 amRNSDirector/PDMR Shareholding
11th Oct 20197:00 amRNSTransaction in Own Shares
10th Oct 20197:00 amRNSShare Buyback Programme
23rd Sep 20197:00 amRNSInterim Results
22nd Jul 20197:00 amRNSContract Wins
11th Jun 20197:00 amRNSContract Wins
23rd May 201912:45 pmRNSAGM Statement
23rd Apr 20195:23 pmRNSHolding(s) in Company
18th Apr 20192:30 pmRNSDividend Declaration, Posting of AR&A & AGM Notice
2nd Apr 20194:30 pmRNSDirector/PDMR Shareholding
1st Apr 20197:00 amRNSFinal Results
6th Feb 20197:00 amRNSDirector/PDMR Shareholding
1st Feb 20197:00 amRNSDirector/PDMR Shareholding
30th Jan 20197:00 amRNSTrading Statement
10th Dec 20187:00 amRNSContract Renewals
31st Oct 20187:00 amRNSAppointment of Director
3rd Oct 201811:00 amRNSAppointment of Director
18th Sep 20187:00 amRNSHalf-year Report
14th Aug 20187:00 amRNSIngenta announces two new multi-year contracts
9th Aug 20187:00 amRNSDirectorate Update
26th Jun 20185:58 pmRNSDirector/PDMR Shareholding
18th Jun 20187:00 amRNSIngenta announces new VAR partnership with ATC
24th May 201812:09 pmRNSAGM Statement & Results of AGM
27th Apr 20187:00 amRNSDividend Declaration, Posting of AR&A & AGM Notice
29th Mar 20187:00 amRNSFinal Results
27th Mar 20183:18 pmRNSCapital Reduction
22nd Feb 20187:00 amRNSSainsbury's sign 3-year agreement with Ingenta
19th Feb 201811:36 amRNSResult of General Meeting
26th Jan 20187:01 amRNSNotice of GM and Proposed Capital Reduction
26th Jan 20187:00 amRNSTrading Update
20th Nov 20177:00 amRNSYewno Appoints PCG to Drive Sales
21st Sep 20173:10 pmRNSGrant of Options
19th Sep 201710:16 amRNSDirector/PDMR Shareholding
18th Sep 201712:21 pmRNSDirector/PDMR Shareholding
13th Sep 20177:00 amRNSInterim Results
15th Aug 20177:00 amRNSContract Win
15th Aug 20177:00 amRNSPre Close Trading Update
19th Jun 201711:41 amRNSDirectorate Disclosure
31st May 20173:50 pmRNSResult of AGM
18th May 20172:36 pmRNSPosting of Annual Report and Accounts
7th Apr 20179:28 amRNSDividend Declaration and notice of AGM
3rd Apr 20177:00 amRNSFinal Results
16th Jan 20177:00 amRNSTrading Update
30th Dec 20162:00 pmRNSDirector/PDMR Shareholding
30th Dec 20161:54 pmRNSDirector/PDMR Shareholding
6th Dec 20165:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.